Neuronal intranuclear inclusion disease in a horse

Acta Neuropathologica

Volumn 110, Issue 2, 2005, Pages 191-195

  Pumarola, M ^a   Vidal, E ^a   Trens, J M ^b   Serafin A ^a   Marquez, M ^a   Ferrer, I ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Hospital Universitari de Bellvitge ^*  (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Clusterin; Horse; Neuronal intranuclear inclusion; Proteasome

Indexed keywords

ANTIBODY; CLUSTERIN; PROTEASOME; PROTEIN SUBUNIT; UBIQUITIN;

ANIMAL TISSUE; ARTICLE; ATAXIA; AUTOFLUORESCENCE; BRAIN NERVE CELL; BRAIN STEM; CELL GRANULE; CELL LOSS; CELL NUCLEUS INCLUSION BODY; CENTRAL NERVOUS SYSTEM; CORRELATION ANALYSIS; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HORSE; HORSE DISEASE; HUMAN VERSUS ANIMAL COMPARISON; MOTOR DYSFUNCTION; NEOCORTEX; NEUROLOGIC DISEASE; NONHUMAN; OCCIPITAL CORTEX; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

ANIMALS; BRAIN; CLUSTERIN; FEMALE; HORSES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRANUCLEAR INCLUSION BODIES; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE PROTEINS; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; SPINAL CORD; UBIQUITIN;

EID: 24344482470     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-1033-5     Document Type: Article

References (21)

1. Bugiani O, Giaccone G, Frigerio L, Farlow MR, Ghetti B, Tagliavini F (1994) Apolipoprotein E and J in immunoreactivity in Gerstmann-Straüssler-Scheinker disease. Neurobiol Aging 15:S156-S157
2. Ferrer I, Carmona M, Blanco R, Moreno D, Torrejón-Escribano B, Olivé M (2005) Involvement of clusterin and the aggresome in abnormal protein deposition in myofibrillar myopathies and inclusion body myositis. Brain Pathol 15:101-108 1:CAS:528:DC%2BD2MXktlOhtrk%3D
3. Freixes M, Puig B, Rodriguez A, Torrejpón-Escribano B, Blanco R, Ferrer I (2004) Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol 108:295-301
4. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 82:373-428 1:CAS:528:DC%2BD38XjtFOnsL4%3D
5. Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427-431 1:CAS:528:DC%2BD38XitFWit7o%3D
6. Haltia M (2003) Neuronal intranuclear inclusion disease. In: Neurodegeneration: The molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 404-406
7. Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC (2004) Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol 19:59-62 15032387
8. Lieberman AP, Robitaille Y, Trojanowski JQ, Dickson DW, Fischbeck KH (1998) Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet 351:884 10.1016/S0140-6736(05)70296-8
9. Lieberman AP, Trojanowski JQ, Leonard DG, Chen K, Barnett J, Leverenz J, Bird T, Robitaille Y, Malandrini A, Fischbeck K (1999) Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease. Ann Neurol 46:271-273 10.1002/1531-8249(199908)46:2<271:AID-ANA21>3.0.CO;2-M
10. McGeer PL, Kawamata T, Walker DG (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337-341 10.1016/ 0006-8993(92)90071-G
11. O'Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ (2000) Neuronal intranuclear inclusion disease and juvenile parkinsonism. Mov Disord 15:990'-995 10.1002/ 1531-8257(200009)15:5<990:AID-MDS1035>3.0.CO;2-I
12. Rosenberg ME, Silkensen J (1995) Clusterin: Physiological and pathological considerations. Int Biochem Cell Biol 27:633-645 10.1016/ 1357-2725(95)00027-M
13. Sasaki K, Doh-ura K, Ironside JW, Iwaki T (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol 103:199-208
14. Sasaki K, Doh-ura K, Wakisawa Y, Iwaki T (2002) Clusterin/apolipoprotein J is associated with cortical Lewy bodies: Immunohistochemical study in cases with α-synucleinopathies. Acta Neuropathol 104:225-230
15. Schmidt T, Lindenberg K, Krebs A, Schöls L, Lacone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer G (2002) Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 51:302-310 10.1002/ ana.10101
16. Seilhean D, Takahashi J, El Hachimi KH, Fujigasaki H, Lebre AS, Biancalana V, Durr A, Salachas F, Hogenhuis J, The H de, Hauw JJ, Meininger V, Brice A, Duyckaerts C (2004) Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol 108:81-87
17. Sloane AE, Becker LE, Ang LC, Wark J, Haslam RH (1994) Neuronal intranuclear hyaline inclusion disease with progressive cerebellar ataxia. Pediatr Neurol 10:61-66 10.1016/0887-8994(94)90070-1
18. Takahashi J, Fukuda T, Tanaka J, Minamitani M, Fujigasaki H, Uchihara T (2000) Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol 99:589-594
19. Takahashi J, Tanaka J, Arai K, Funata N, Hattori T, Fukuda T, Fujigasaki H, Uchihara T (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 60:369-376 1:CAS:528:DC%2BD3MXjtFKmtr0%3D
20. Takahashi-Fujigasaki J (2003) Neuronal intranuclear hyaline inclusion disease. Neuropathology 23:351-359 10.1046/j.1440-1789.2003.00524.x
21. Uchihara T, Tanaka J, Funata N, Arai K, Hattori T (2003) Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 105: 103-108